Endocarditis in injection drug users

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Injection drug use is a significant risk factor for infective endocarditis.
• Endocarditis in injection drug users (IDUs) presents differently than in non-IDUs, often affecting the right side of the heart.
• Clinical manifestations in IDUs include fever and pulmonary emboli, contrasting with left-sided emboli in non-IDUs.

Purpose of the Study:

• To delineate the distinct clinical features, diagnostic approaches, and treatment strategies for endocarditis in injection drug users.
• To highlight the diagnostic utility of blood cultures and echocardiography in this specific population.
• To identify prognostic factors influencing outcomes in IDUs with endocarditis.

Main Methods:

• Review of clinical data and diagnostic findings in patients with endocarditis.
• Emphasis on microbiological investigations (blood cultures) and imaging (echocardiography).
• Analysis of treatment regimens and patient outcomes.

Main Results:

• Endocarditis in IDUs predominantly affects the right side of the heart.
• Fever and pulmonary emboli are common presenting symptoms.
• Blood cultures and echocardiography are highly effective for diagnosis in this group.
• Staphylococcal species are the most common pathogens.
• Penicillin and aminoglycoside are the recommended treatments.
• Left-sided endocarditis or co-infection with HIV indicates a poor prognosis.

Conclusions:

• Injection drug use leads to a unique presentation of endocarditis, primarily impacting the right heart.
• Prompt diagnosis via blood cultures and echocardiography is crucial.
• Appropriate antibiotic therapy, often penicillin and aminoglycoside, is indicated.
• Adverse outcomes are associated with left-sided involvement or HIV co-infection in IDUs.